Tower Research Capital (TRC)’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $30.9K | Sell |
|
|||||
|
2025
Q2 | $164K | Buy |
|
|||||
|
2025
Q1 | $64.9K | Buy |
|
|||||
|
2024
Q4 | $27.9K | Buy |
|
|||||
|
2024
Q3 | $16K | Sell |
|
|||||
|
2024
Q2 | $159K | Buy |
|
|||||
|
2024
Q1 | $12.4K | Sell |
|
|||||
|
2023
Q4 | $92.3K | Buy |
|
|||||
|
2023
Q3 | $66.4K | Buy |
|
|||||
|
2023
Q2 | $16.5K | Buy |
|
|||||
|
2023
Q1 | $11K | Buy |
|
|||||
|
2022
Q4 | $11K | Sell |
|
|||||
|
2022
Q3 | $26K | Sell |
|
|||||
|
2022
Q2 | $38K | Sell |
|
|||||
|
2022
Q1 | $108K | Buy |
|
|||||
|
2021
Q4 | $14K | Buy |
|
|||||
|
2021
Q3 | $10K | Sell |
|
|||||
|
2021
Q2 | $34K | Buy |
|
|||||
|
2021
Q1 | $12K | Sell |
|
|||||
|
2020
Q4 | $27K | Buy |
|